Copyright
©The Author(s) 2024.
World J Gastroenterol. May 14, 2024; 30(18): 2440-2453
Published online May 14, 2024. doi: 10.3748/wjg.v30.i18.2440
Published online May 14, 2024. doi: 10.3748/wjg.v30.i18.2440
Project | Subgroup population | Remaining population | P value |
(n = 117) | (n = 162) | ||
Demographics | |||
Male | 49 (41.9) | 77 (47.5) | 0.35 |
Age (yr) | 44.0 (32.0, 53.0) | 40.0 (30.0, 53.3) | 0.38 |
BMI (kg/m2) | 26.4 ± 3.4 | 27.6 ± 3.4 | 0.08 |
Metabolic disease | |||
Dysglycemia | 80 (68.4) | 107 (66.0) | 0.68 |
Hypertension | 33 (28.2) | 39 (24.1) | 0.44 |
Hyperlipidemia | 21 (17.9) | 16 (9.9) | 0.05 |
Hypertriglyceridemia | 69 (59.0) | 81 (50.0) | 0.14 |
Low HDL | 89 (76.1) | 113 (69.8) | 0.24 |
Serologic indicators | |||
TC (mmol/L) | 5.0 ± 1.0 | 4.8 ± 1.0 | 0.19 |
TG (mmol/L) | 2.0 (1.3, 2.9) | 1.7 (1.3, 2.5) | 0.46 |
HDL-C (mmol/L) | 1.0 (0.9, 1.2) | 1.0 (0.9, 1.2) | 0.98 |
LDL-C (mmol/L) | 3.0 ± 0.9 | 2.9 ± 0.8 | 0.43 |
Fasting blood glucose (mmol/L) | 5.9 (5.5, 6.8) | 5.8 (5.3, 6.7) | 0.38 |
PLT (× 109/L) | 229.2 ± 71.1 | 218.1 ± 62.0 | 0.17 |
ALT (U/L) | 72.5 (46.0, 125.0) | 100.1 (62.7, 152.6) | 0.01 |
AST (U/L) | 46.2 (29.8, 77.4) | 52.5 (34.9, 83.1) | 0.11 |
ALP (U/L) | 77.6 (66.1, 98.1) | 83.6 (65.6, 101.2) | 0.49 |
GGT (U/L) | 71.4 (43.5, 105.1) | 58.6 (37.5, 103.2) | 0.25 |
TBIL (μmol/L) | 12.4 (9.5, 16.4) | 12.3 (9.2, 16.7) | 0.88 |
ALB (g/L) | 46.6 (42.7, 49.0) | 45.6 (43.1, 48.9) | 0.41 |
HGB (g/L) | 145.0 (136.0, 156.0) | 143.5 (131.0, 156.1) | 0.16 |
Apolipoprotein A1 (g/L) | 1.4 (1.2, 1.5) | 1.3 (1.1, 1.5) | 0.22 |
Apolipoprotein B (g/L) | 1.0 (0.8, 1.1) | 0.9 (0.7, 1.1) | 0.10 |
Cr (μmol/L) | 61.5 (52.7, 71.3) | 61.5 (52.0, 73.1) | 0.93 |
Urea (mmol/L) | 4.5 (3.8, 5.2) | 4.7 (3.8, 5.4) | 0.41 |
Uric acid (μmol/L) | 369.0 (304.0, 436.5) | 363.5 (296.0, 433.0) | 0.64 |
eGFR (mL/min) | 112.5 (103.4, 120.2) | 107.0 (98.5, 119.5) | 0.24 |
PT (s) | 11.3 (10.7, 11.9) | 11.3 (10.6, 11.9) | 0.90 |
Non-invasive models | |||
FIB-4 | 1.0 (0.6, 1.6) | 0.9 (0.6, 1.6) | 0.88 |
APRI | 0.5 (0.3, 1.0) | 0.6 (0.4, 1.0) | 0.08 |
Forns index | 4.4 (3.0, 5.6) | 4.1 (3.0, 5.7) | 0.74 |
ARR | 0.6 (0.5, 0.8) | 0.5 (0.4, 0.7) | 0.06 |
S index | 0.1 (0.1, 0.2) | 0.1 (0.1, 0.3) | 0.53 |
GPR | 0.7 (0.5, 1.2) | 0.7 (0.4, 1.2) | 0.45 |
- Citation: Yin JY, Yang TY, Yang BQ, Hou CX, Li JN, Li Y, Wang Q. FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis. World J Gastroenterol 2024; 30(18): 2440-2453
- URL: https://www.wjgnet.com/1007-9327/full/v30/i18/2440.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i18.2440